NLS Pharmaceutics AG is a biotechnology business based in the US. NLS Pharmaceutics shares (NLSP) are listed on the NASDAQ and all prices are listed in US Dollars. NLS Pharmaceutics employs 6 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in NLS Pharmaceutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NLSP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

NLS Pharmaceutics stock price (NASDAQ: NLSP)
Use our graph to track the performance of NLSP stocks over time.NLS Pharmaceutics shares at a glance
Latest market close | $0.53 |
---|---|
52-week range | $0.46 - $3.72 |
50-day moving average | $0.69 |
200-day moving average | $1.37 |
Wall St. target price | $7.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.00 |
Buy NLS Pharmaceutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy NLS Pharmaceutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NLS Pharmaceutics price performance over time
Historical closes compared with the close of $0.5305 from 2022-07-01
1 week (2022-06-28) | -12.95% |
---|---|
1 month (2022-06-06) | -18.36% |
3 months (2022-04-06) | -55.79% |
6 months (2022-01-06) | -58.55% |
1 year (2021-07-06) | -82.66% |
---|---|
2 years (2020-07-02) | N/A |
3 years (2019-07-02) | N/A |
5 years (2017-07-02) | N/A |
NLS Pharmaceutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -212.52% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | $0.04 |
Market capitalisation | $10.4 million |
TTM: trailing 12 months
NLS Pharmaceutics share dividends
We're not expecting NLS Pharmaceutics to pay a dividend over the next 12 months.
You may also wish to consider:
- Novartis AG ADR (NVS.US) (3.94% forward annual dividend yield)
NLS Pharmaceutics overview
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland. .
Frequently asked questions
What percentage of NLS Pharmaceutics is owned by insiders or institutions?Currently 28.992% of NLS Pharmaceutics shares are held by insiders and 8.844% by institutions. How many people work for NLS Pharmaceutics?
Latest data suggests 6 work at NLS Pharmaceutics. When does the fiscal year end for NLS Pharmaceutics?
NLS Pharmaceutics's fiscal year ends in December. Where is NLS Pharmaceutics based?
NLS Pharmaceutics's address is: The Circle 6, Zurich, Switzerland, 8058 What is NLS Pharmaceutics's ISIN number?
NLS Pharmaceutics's international securities identification number is: CH0523961370
More guides on Finder
-
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
-
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
-
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert